EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sequentially Self-Assembled Supramolecular Nanocomplexes Enable Systemic Cas9 RNP Delivery and In Vivo Tumor Genome Editing

Takumi Matsuo iD, Yuto Honda iD, Toshizumi Chino, Takahiro Nomoto iD, Yuriko Osakabe, Yutaka Miura iD, Nobuhiro Nishiyama iD

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c14858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Takumi Matsuo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kan…. Hauptthemen laut MEDLINE: Gene Editing, Ribonucleoproteins, CRISPR-Associated Protein 9, Neoplasms. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In vivo genome editing utilizing Cas9/sgRNA ribonucleoproteins (RNPs) holds substantial therapeutic promise, yet rapid bloodstream clearance and degradation of RNPs have hindered its accumulation within the target site and effective gene editing. Herein, we report a supramolecular ternary complex platform where RNPs are co-assembled with tannic acid (TA) and phenylboronic acid (PBA)-conjugated polymers through sequential self-assembly. This ∼30 nm core–shell structure protects RNPs from enzymatic degradation and dissociates selectively at endosomal pH. Upon intravenous administration in subcutaneous tumor-bearing mice, the ternary complex exhibits prolonged blood circulation and preferential tumor accumulation, achieving 37.2% gene editing at tumor sites compared with only 1.5% for free RNPs. The platform successfully disrupts PLK1 in subcutaneous tumors, accompanied by significant tumor growth suppression. This is further applied to a KRASG13D-mutant tumor model, in which treatment delayed tumor growth. By integrating sequential supramolecular self-assembly with stimuli-responsive cargo release, this strategy presents a promising approach for systemic RNP delivery and tumor genome editing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingRibonucleoproteinsCRISPR-Associated Protein 9NeoplasmsAnimalsBoronic AcidsMiceHumansTanninsCell Line, TumorCRISPR-Cas SystemsPolo-Like Kinase 1Protein Serine-Threonine KinasesCell Cycle ProteinsProto-Oncogene Proteins

Stichwörter der Autor:innen

CRISPR/Cas9block copolymerboronic acidself-assemblytannic acid

Substanzen

Boronic AcidsTanninsRibonucleoproteinsPolo-Like Kinase 1benzeneboronic acidProtein Serine-Threonine KinasesCell Cycle ProteinsCRISPR-Associated Protein 9Proto-Oncogene Proteins

Autor:innen und Institutionen

  • Laboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kanagawa226-8503, Japan.
  • Department of Life Science and Technology, School of Life Science and Technology, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kanagawa226-8503, Japan.
  • Innovation Center of Nanomedicine (iCONM), Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa210-0821, Japan.
  • Department of Life Sciences, Graduate School of Arts and Sciences, the University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo153-8902, Japan.

ORCID-Profile: Takumi Matsuo, Yuto Honda, Takahiro Nomoto, Yutaka Miura, Nobuhiro Nishiyama

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Science and Technology Agency

Zitieren

APA

Matsuo, T., Honda, Y., Chino, T., Nomoto, T., Osakabe, Y., Miura, Y., & Nishiyama, N. (2026). Sequentially Self-Assembled Supramolecular Nanocomplexes Enable Systemic Cas9 RNP Delivery and In Vivo Tumor Genome Editing. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c14858

Vancouver

Matsuo T, Honda Y, Chino T, Nomoto T, Osakabe Y, Miura Y, et al. Sequentially Self-Assembled Supramolecular Nanocomplexes Enable Systemic Cas9 RNP Delivery and In Vivo Tumor Genome Editing. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c14858

BibTeX
@article{Matsuo2026,
  author = {Matsuo, Takumi and Honda, Yuto and Chino, Toshizumi and Nomoto, Takahiro and Osakabe, Yuriko and Miura, Yutaka and Nishiyama, Nobuhiro},
  title = {Sequentially Self-Assembled Supramolecular Nanocomplexes Enable Systemic Cas9 RNP Delivery and In Vivo Tumor Genome Editing},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c14858}
}
Kostenlos starten →